COBALT advised Biogen on launching its operations in Latvia and Estonia

COBALT advised US-based biotech giant Biogen on launching its business operations in Latvia and Estonia.

Our work included legal assistance on structuring and localization of Biogen distribution model, the establishment of company branches and related corporate, regulatory and employment advice.

COBALT team included Partner Indriķis Liepa, Associates Marija Berdova, Ivo Maskalāns and Jānis Sarāns from Latvia and Partner Karina Paatsi and Senior Associate Heili Haabu from Estonia.

Biogen was founded in 1978 and is one of the largest biotech companies, employing more than 7400 employees worldwide. the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis.